Citations

Mayo Clinic

Showing 10 of 108585 citations.

SHORT-TERM SAFETY OF 2 MG INTRAVITREAL ZIV-AFLIBERCEPT
Chhablani, Jay , Dedhia, Chintan , Peguda, Hari Kumar , Stewart, Michael, group, on behalf of Ziv-aflibercept study, group, on behalf of Ziv-aflibercept study

Retina | January 4, 2017 | Volume: 37 | Issue: 10 | Pages: 1859-1865

10.1097/iae.0000000000001440 | PMID 28060148 Get It

Purpose: To evaluate the safety of single intravitreal 2 mg ziv-aflibercept (0.08 mL) injections for the treatment of choroidal neovascular membranes (CNVM). Methods: Eyes with choroidal neovascular membranes because of several conditions each received single intravitreal injections of 2 mg ziv-aflibercept (0.08 mL). Comprehensive ophthalmic examinations and detailed systemic evaluations were performed at baseline and Days 1, 7, and 30 after injections. Standard electroretinography was performed at baseline and Day 30. Primary outcome measures consisted of safety assessments (signs of clinical toxicity and electroretinographic abnormalities). Secondary outcome measures included changes in best-corrected visual acuity (BCVA) and central subfield thickness (CST) of the macula. Results: Twenty-one eyes of 20 patients (12 males) received injections. Etiologies responsible for the choroidal neovascular membranes included age-related macular degeneration (14), polypoidal choroidal vasculopathy (PCV) (3), myopia (2), and idiopathic juxtafoveal telangiectasia (2). None of the patients complained of worsening vision or pain after the intravitreal injections and no intraocular inflammation was seen. No significant changes in the electroretinographic b/a ratio from baseline to 1 month were measured (scotopic: P = 0.89; photopic: P = 0.13) and mean intraocular pressures were unchanged (14.2 ± 3.6 vs. 13.7 ± 3.0 mmHg; P = 0.62). Mean best-corrected visual acuity did not change significantly from baseline to 1 month (0.66 ± 0.37 logMAR [Snellen equivalent: 20/100] vs. 0.61 ± 0.35 logMAR [Snellen equivalent: 20/80]; P = 0.72) but significant improvements in central subfield thickness were seen (343 ± 177 vs. 210 ± 133 μ m; P = 0.01). Conclusion: Single intravitreal injections of 2 mg ziv-aflibercept (0.08 mL) appear to be safe through 1 month.
Faculty Opinions recommendation of Comparison of White Light, Photodynamic Diagnosis, and Narrow-band Imaging in Detection of Carcinoma In Situ or Flat Dysplasia at Transurethral Resection of the Bladder: the DaBlaCa-8 Study.
Humphreys, Mitchell R. , McAdams, Sean , McAdams, Sean

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 4, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727041741.793526548 Get It

Behavioral state classification in epileptic brain using intracranial electrophysiology
Křemen, Václav , Duque, Juliano J., Brinkmann, Benjamin H. , Berry, Brent , Kucewicz, Michał T. , Khadjevand, Fatemeh, Stead, Matt, Louis, Erik K. St. , Berry, Brent M, Van Gompel, Jamie, St Louis, Erik K, Gompel, Jamie J. Van , Worrell, Gregory A. , St Louis, E K , Brinkmann, Benjamin H , Kremen, Vaclav , Kucewicz, Michal

Journal of Neural Engineering | January 4, 2017 | Volume: 14 | Issue: 2 | Pages: 026001

10.1088/1741-2552/aa5688 | PMID 28050973 Get It

Abstract Objective . Automated behavioral state classification can benefit next generation implantable epilepsy devices. In this study we explored the feasibility of automated awake (AW) and slow wave sleep (SWS) classification using wide bandwidth intracranial EEG (iEEG) in patients undergoing evaluation for epilepsy surgery. Approach . Data from seven patients (age 34 ± 12 , 4 women) who underwent intracranial depth electrode implantation for iEEG monitoring were included. Spectral power features (0.1–600 Hz) spanning several frequency bands from a single electrode were used to train and test a support vector machine classifier. Main results . Classification accuracy of 97.8 ± 0.3% (normal tissue) and 89.4 ± 0.8% (epileptic tissue) across seven subjects using multiple spectral power features from a single electrode was achieved. Spectral power features from electrodes placed in normal temporal neocortex were found to be more useful (accuracy 90.8 ± 0.8%) for sleep-wake state classification than electrodes located in normal hippocampus (87.1 ± 1.6%). Spectral power in high frequency band features (Ripple (80–250 Hz), Fast Ripple (250–600 Hz)) showed comparable performance for AW and SWS classification as the best performing Berger bands (Alpha, Beta, low Gamma) with accuracy ⩾90% using a single electrode contact and single spectral feature. Significance . Automated classification of wake and SWS should prove useful for future implantable epilepsy devices with limited computational power, memory, and number of electrodes. Applications include quantifying patient sleep patterns and behavioral state dependent detection, prediction, and electrical stimulation therapies.
Serum alkylresorcinols as biomarkers of dietary gluten exposure in coeliac disease
Choung, Rok Seon , Marietta, Eric, Dyke, Carol T. Van, Ross, Alastair B. , Murray, Joseph A. , Choung, Rok Seon

Alimentary Pharmacology & Therapeutics | January 4, 2017 | Volume: 45 | Issue: 5 | Pages: 643-652

10.1111/apt.13917 | PMID 28052442 Get It

SummaryBackgroundTherapy for coeliac disease (CD) mainly relies on following a gluten‐free diet (GFD); however, a serum marker for gluten intake has yet to be established.AimTo evaluate the utility of alkylresorcinol concentrations for detecting gluten intake in studies of human and mouse.MethodsAlkylresorcinol concentrations were compared among treated patients with coeliac disease (n = 34), untreated coeliac disease patients (n = 36) and controls (n = 33). Furthermore, seven additional coeliac disease patients whose serum samples were available at diagnosis and after GFD were evaluated. In mice studies, alkylresorcinol concentrations were compared in the serum of five mice fed a regular chow and 10 mice fed lifelong with a gluten‐free chow. In addition, the effect of adding gluten on changes of alkylresorcinol concentrations was also evaluated.ResultsTotal alkylresorcinol concentrations were significantly lower in treated with coeliac disease [median (IQR), 3 (2–8) nmol/L], compared to untreated patients [median (IQR), 32 (11–74) nmol/L; P < 0.0001] or healthy controls [median (IQR), 54 (23–112) nmol/L; P < 0.0001]. Moreover, alkylresorcinol concentrations in coeliac disease patients significantly decreased after introduction of a GFD (median, 34 nmol/L at diagnosis vs. 5 nmol/L after GFD, P = 0.02). In the mice, median (IQR) total alkylresorcinol concentrations in serum samples of mice fed lifelong with a gluten‐free chow was 1.8 (1.6–2.3) nmol/L, which was further significantly increased to 16 (11–22) nmol/L after 8 days of feeding with the gluten‐free chow that had gluten added to it. (P = 0.008).ConclusionSerum alkylresorcinol concentrations could be a useful marker for dietary gluten in coeliac disease.
BARD1 nonsense variant c.1921C>T in a patient with recurrent breast cancer
Gass, Jennifer , Tatro, Madeline, Blackburn, Patrick R. , Hines, Stephanie L., Atwal, Paldeep S. , Blackburn, Patrick , Hines, Stephanie, Atwal, Paldeep S

Clinical Case Reports | January 4, 2017 | Volume: 5 | Issue: 2 | Pages: 104-107

10.1002/ccr3.793 | PMID 28174632 Get It

Key Clinical Message One of the strongest risk factors predisposing patients to breast cancer is a positive family history. In our study, we describe a patient diagnosed with multiple breast cancer tumors. Genetic analysis revealed a pathogenic variant in BARD1 , which is associated with an increased risk of developing certain types of cancer.
Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study
Sundaresh, Vishnu , Brito, Juan P. , Prabin, Thapa, Bahn, Rebecca S. , Stan, Marius N. , Stan, Marius N , Brito, Juan P

Thyroid | January 4, 2017 | Volume: 27 | Issue: 4 | Pages: 497-505

10.1089/thy.2016.0343 | PMID 28049375 Get It

Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype
Nasr, Samih H. , Dasari, Surendra , Mills, John R. , Theis, Jason D. , Zimmermann, Michael T. , Vrana, Julie A., Lester, Steven J., McLaughlin, Brooke M. , Gillespie, Robert L. , Highsmith, W. Edward, Kurtin, Paul J. , Fonseca, Rafaël , Lee, John J. , Dispenzieri, Angela , Zimmermann, Michael T

Journal of the American Society of Nephrology | January 3, 2017 | Volume: 28 | Issue: 2 | Pages: 431-438

10.1681/asn.2016090951 | PMID 28049649 Get It

Lysozyme amyloidosis (ALys) is a rare form of hereditary amyloidosis that typically manifests with renal impairment, gastrointestinal (GI) symptoms, and sicca syndrome, whereas cardiac involvement is exceedingly rare and neuropathy has not been reported. Here, we describe a 40-year-old man with renal impairment, cardiac and GI symptoms, and peripheral neuropathy. Renal biopsy specimen analysis revealed amyloidosis with extensive involvement of glomeruli, vessels, and medulla. Amyloid was also detected in the GI tract. Echocardiographic and electrocardiographic findings were consistent with cardiac involvement. Proteomic analysis of Congo red–positive renal and GI amyloid deposits detected abundant lysozyme C protein. DNA sequencing of the lysozyme gene in the patient and his mother detected a heterozygous c.305T>C alteration in exon 3, which causes a leucine to serine substitution at codon 102 (Human Genome Variation Society nomenclature: p.Leu102Ser; legacy designation: L84S). We also detected the mutant peptide in the proband’s renal and GI amyloid deposits. PolyPhen analysis predicted that the mutation damages the encoded protein. Molecular dynamics simulations suggested that the pathogenesis of ALys p.Leu102Ser is mediated by shifting the position of the central β -hairpin coordinated with an antiparallel motion of the C-terminal helix, which may alter the native-state structural ensemble of the molecule, leading to aggregation-prone intermediates.
Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells
Gu, Juan , Kaufman, Gregory P., Mavis, Cory, Czuczman, Myron S., Hernandez‐Ilizaliturri, Francisco J.

Oncotarget | January 3, 2017 | Volume: 8 | Issue: 8 | Pages: 12741-12753

10.18632/oncotarget.14405 | PMID 28055975 Get It

Pigmented skin lesions, dermatomal maps, and clinical anatomists
Spinner, Robert J. , Zuckerman, Scott L.

Clinical Anatomy | January 3, 2017 | Volume: 30 | Issue: 4 | Pages: 422-424

10.1002/ca.22825 | PMID 28044373 Get It

Advocating for use of the ALARA principle in the context of medical imaging fails to recognize that the risk is hypothetical and so serves to reinforce patients' fears of radiation
Siegel, Jeffry A. , McCollough, Cynthia H. , Orton, Colin G.

Medical Physics | January 3, 2017 | Volume: 44 | Issue: 1 | Pages: 3-6

10.1002/mp.12012 | PMID 28044339 Get It